Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations

Documenti analoghi

• Longitudinal monitoring of cabotegravir and rilpivirine exposure from hair strand concentrations
  di: E. Rosen, et al.
  Pubblicazione: (2025)
• Effectiveness and Persistence of Long‐Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort
  di: Jara Llenas‐García, et al.
  Pubblicazione: (2026)
• Pharmacokinetics of long‐acting cabotegravir and rilpivirine in seminal plasma throughout the dosing interval
  di: N. Neverette, et al.
  Pubblicazione: (2025)
• Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
  di: Shakir Atoyebi, et al.
  Pubblicazione: (2024)
• Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)
  di: Filippo Lagi, et al.
  Pubblicazione: (2025)